Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Tumor-Agnostic 2Thoracic 2NET 2Endocrine 2Other solid neoplasm 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Advanced Solid Tumor 3Mesothelioma 2Advanced Solid Tumors 2Stomach Neoplasms 1Solid Tumors 1Sarcoma 1Neuroendocrine Tumors 1Neoplasms 1Mesothelioma, Malignant 1Major Advanced Solid Tumors Other Than Colorectal 1Glioblastoma 1Gastro-enteropancreatic neuroendocrine tumor 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1ADVANCED SOLID TUMORS 1

Interventions

pembrolizumab 4Cisplatin 3Carboplatin 3budigalimab 2Pemetrexed 2Paclitaxel 2Immunotherapy 2Etoposide 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2venetoclax 1trametinib 1spartalizumab 1sargramostim 1rovalpituzumab tesirine 1ribociclib 1poly ICLC 1fludarabine 1enzalutamide 1entinostat 1belinostat 1UV1 vaccine 1Tomography, Optical Coherence 1Thrombopoietin 1Sunitinib 1Sirolimus 1Quality of Life 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × PM 01183 × Other solid neoplasm × Clear all
NCT02611024 2025-07-09

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

PharmaMar

Phase 1/2 Completed
316 enrolled
CNSEndocrineGastrointestinalGynecologicNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Ovarian Epithelial, Glioblastoma, Mesothelioma, Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡